Comprehensive Lipid Profiling Recapitulates Enhanced Lipolysis and Fatty Acid Metabolism in Intimal Foamy Macrophages From Murine Atherosclerotic Aorta
4
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Lipid accumulation in macrophages is a prominent phenomenon observed in atherosclerosis. Previously, intimal foamy macrophages (FM) showed decreased inflammatory gene expression compared to intimal non-foamy macrophages (NFM). Since reprogramming of lipid metabolism in macrophages affects immunological functions, lipid profiling of intimal macrophages appears to be important for understanding the phenotypic changes of macrophages in atherosclerotic lesions. While lipidomic analysis has been performed in atherosclerotic aortic tissues and cultured macrophages, direct lipid profiling has not been performed in primary aortic macrophages from atherosclerotic aortas. We utilized nanoflow ultrahigh-performance liquid chromatography-tandem mass spectrometry to provide comprehensive lipid profiles of intimal non-foamy and foamy macrophages and adventitial macrophages from Ldlr−/− mouse aortas. We also analyzed the gene expression of each macrophage type related to lipid metabolism. FM showed increased levels of fatty acids, cholesterol esters, phosphatidylcholine, lysophosphatidylcholine, phosphatidylinositol, and sphingomyelin. However, phosphatidylethanolamine, phosphatidic acid, and ceramide levels were decreased in FM compared to those in NFM. Interestingly, FM showed decreased triacylglycerol (TG) levels. Expressions of lipolysis-related genes including Pnpla2 and Lpl were markedly increased but expressions of Lpin2 and Dgat1 related to TG synthesis were decreased in FM. Analysis of transcriptome and lipidome data revealed differences in the regulation of each lipid metabolic pathway in aortic macrophages. These comprehensive lipidomic data could clarify the phenotypes of macrophages in the atherosclerotic aorta.
Abstract
Lipid accumulation in macrophages is a prominent phenomenon observed in atherosclerosis. Previously, intimal foamy macrophages (FM) showed decreased inflammatory gene expression compared to intimal non-foamy macrophages (NFM). Since reprogramming of lipid metabolism in macrophages affects immunological functions, lipid profiling of intimal macrophages appears to be important for understanding the phenotypic changes of macrophages in atherosclerotic lesions. While lipidomic analysis has been performed in atherosclerotic aortic tissues and cultured macrophages, direct lipid profiling has not been performed in primary aortic macrophages from atherosclerotic aortas. We utilized nanoflow ultrahigh-performance liquid chromatography-tandem mass spectrometry to provide comprehensive lipid profiles of intimal non-foamy and foamy macrophages and adventitial macrophages from Ldlr−/− mouse aortas. We also analyzed the gene expression of each macrophage type related to lipid metabolism. FM showed increased levels of fatty acids, cholesterol esters, phosphatidylcholine, lysophosphatidylcholine, phosphatidylinositol, and sphingomyelin. However, phosphatidylethanolamine, phosphatidic acid, and ceramide levels were decreased in FM compared to those in NFM. Interestingly, FM showed decreased triacylglycerol (TG) levels. Expressions of lipolysis-related genes including Pnpla2 and Lpl were markedly increased but expressions of Lpin2 and Dgat1 related to TG synthesis were decreased in FM. Analysis of transcriptome and lipidome data revealed differences in the regulation of each lipid metabolic pathway in aortic macrophages. These comprehensive lipidomic data could clarify the phenotypes of macrophages in the atherosclerotic aorta.
참고문헌 (48)
- VanderLaan PA, "Site specificity of atherosclerosis : site-selective responses to atherosclerotic modulators", Arterioscler Thromb Vasc Biol, 24, pp.12~22 (2004)
- Zhang S, "Foam cell formation in atherosclerosis : HDL and macrophage reverse cholesterol transport", Conf Publ, 2013, pp.825~835 (2013)
- Cole JE, "Immune cell census in murine atherosclerosis : cytometry by time of flight illuminates vascular myeloid cell diversity", Cardiovasc Res, 114, pp.1360~1371 (2018)
- Glass CK, "Atherosclerosis. The road ahead", Cell, 104, pp.503~516 (2001)
- Fahy E, "A comprehensive classification system for lipids", J Lipid Res, 46, pp.839~861 (2005)
- Brouwers JF, "Rapid separation and identification of phosphatidylethanolamine molecular species", J Lipid Res, 40, pp.164~169 (1999)
- Wenk MR, "The emerging field of lipidomics", Nat Rev Drug Discov, 4, pp.594~610 (2005)
- Stegemann C, "Comparative lipidomics profiling of human atherosclerotic plaques", Circ Cardiovasc Genet, 4, pp.232~242 (2011)
- Wilson PW, "Obesity, diabetes, and risk of cardiovascular disease in the elderly", Am J Geriatr Cardiol, 11, pp.119~124 (2002)
- Santos CR, "Lipid metabolism in cancer", FEBS J, 279, pp.2610~2623 (2012)
- Lee GB, "Plasma lipid profile comparison of five different cancers by nanoflow ultrahigh performance liquid chromatography-tandem mass spectrometry", Anal Chim Acta, 1063, pp.117~126 (2019)
- Remmerie A, "Macrophages and lipid metabolism", Cell Immunol, 330, pp.27~42 (2018)
- Kim K, "Transcriptome analysis reveals nonfoamy rather than foamy plaque macrophages are proinflammatory in atherosclerotic murine models", Circ Res, 123, pp.1127~1142 (2018)
- Zhang C, "Quantitative profiling of glycerophospholipids during mouse and human macrophage differentiation using targeted mass spectrometry", Sci Rep, 7, pp.412~ (2017)
- Hsieh WY, "Toll-like receptors induce signal-specific reprogramming of the macrophage lipidome", Cell Metab, 32, pp.128~143 (2020)
- Paul A, "Cholesterol acceptors regulate the lipidome of macrophage foam cells", Int J Mol Sci, 20, pp.3784~ (2019)
- Martin M, "Cutadapt removes adapter sequences from high-throughput sequencing reads", EMBnet J, 17, pp.10~12 (2019)
- Dobin A, "STAR : ultrafast universal RNA-seq aligner", Bioinformatics, 29, pp.15~21 (2013)
- Anders S, "HTSeq--a Python framework to work with high-throughput sequencing data", Bioinformatics, 31, pp.166~169 (2015)
- Love MI, "Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2", Genome Biol, 15, pp.550~ (2014)
- Wang L, "RSeQC : quality control of RNA-seq experiments", Bioinformatics, 28, pp.2184~2185 (2012)
- Castoldi A, "Triacylglycerol synthesis enhances macrophage inflammatory function", Nat Commun, 11, pp.4107~ (2020)
- Lone AM, "Proinflammatory and immunoregulatory roles of eicosanoids in T cells", Front Immunol, 4, pp.130~ (2013)
- Meikle PJ, "Plasma lipidomic analysis of stable and unstable coronary artery disease", Arterioscler Thromb Vasc Biol, 31, pp.2723~2732 (2011)
- Tallima H, "Arachidonic acid : physiological roles and potential health benefits-a review", J Adv Res, 11, pp.33~41 (2017)
- Xu M, "Arachidonic acid metabolism controls macrophage alternative activation through regulating oxidative phosphorylation in PPARγ dependent manner", Front Immunol, 12, pp.618501~ (2021)
- Gaudet P, "Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium", Brief Bioinform, 12, pp.449~462 (2011)
- Ishimoto K, "Sterol-mediated regulation of human lipin 1 gene expression in hepatoblastoma cells", J Biol Chem, 284, pp.22195~22205 (2009)
- Eichmann TO, "Studies on the substrate and stereo", regioselectivity of adipose triglyceride lipase, hormone-sensitive lipase, and diacylglycerol-O-acyltransferases, 2012, pp.287, 41446~41457
- Fruchart-Najib J, "Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5", Biochem Biophys Res Commun, 319, pp.397~404 (2004)
- Brown MS, "The cholesteryl ester cycle in macrophage foam cells. Continual hydrolysis and re-esterification of cytoplasmic cholesteryl esters", J Biol Chem, 255, pp.9344~9352 (1980)
- Garuti R, "The modular adaptor protein autosomal recessive hypercholesterolemia(ARH)promotes low density lipoprotein receptor clustering into clathrin-coated pits", J Biol Chem, 280, pp.40996~41004 (2005)
- Liou HL, "NPC2, the protein deficient in Niemann-Pick C2 disease, consists of multiple glycoforms that bind a variety of sterols", J Biol Chem, 281, pp.36710~36723 (2006)
- Cadigan KM, "Isolation and characterization of Chinese hamster ovary cell mutants deficient in acyl-coenzyme A : cholesterol acyltransferase activity", J Biol Chem, 263, pp.274~282 (1988)
- Shu H, "Emerging roles of ceramide in cardiovascular diseases", Aging Dis, 13, pp.232~245 (2022)
- Leitinger N, "Phenotypic polarization of macrophages in atherosclerosis", Arterioscler Thromb Vasc Biol, 33, pp.1120~1126 (2013)
- Bi Y, "M2 macrophages as a potential target for antiatherosclerosis treatment", Neural Plast, 2019, pp.6724903~ (2019)
- Huang SC, "Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages", Nat Immunol, 15, pp.846~855 (2014)
- Genoula M, "Fatty acid oxidation of alternatively activated macrophages prevents foam cell formation, but Mycobacterium tuberculosis counteracts this process via HIF-1α activation", PLoS Pathog, 16, pp.e1008929~ (2020)
- Yu XH, "Foam cells in atherosclerosis", Clin Chim Acta, 424, pp.245~252 (2013)
- Ménégaut L, "Macrophage fatty acid metabolism and atherosclerosis : the rise of PUFAs", Atherosclerosis, 291, pp.52~61 (2019)
- Grygiel-Górniak B, "Peroxisome proliferator-activated receptors and their ligands : nutritional and clinical implications--a review", Nutr J, 13, pp.17~ (2014)
- Spann NJ, "Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses", Cell, 151, pp.138~152 (2012)
- Orsó E, "Human native, enzymatically modified and oxidized low density lipoproteins show different lipidomic pattern", Biochim Biophys Acta, 1851, pp.299~306 (2015)
- Knuplez E, "An updated review of pro-and anti-inflammatory properties of plasma lysophosphatidylcholines in the vascular system", Int J Mol Sci, 21, pp.4501~ (2020)
- Maciel E, "Lipid remodelling in human melanoma cells in response to UVA exposure", Photochem Photobiol Sci, 16, pp.744~752 (2017)
- Rosenblat M, "Lysophosphatidylcholine(LPC)attenuates macrophage-mediated oxidation of LDL", Biochem Biophys Res Commun, 344, pp.1271~1277 (2006)
- Schmitz G, "Metabolism and atherogenic disease association of lysophosphatidylcholine", Atherosclerosis, 208, pp.10~18 (2010)